Craig Johnson
Fortune : 296 575 $ au 31/05/2026
Fortune : 296 575 $ au 31/05/2026
Craig A. Johnson is currently Lead Independent Director at Heron Therapeutics, Inc. since 2020 and Lead Independent Director at Aurinia Pharmaceuticals, Inc. starting in 2026.
Former roles include Independent Director at La Jolla Pharmaceutical Co. from 2013 to 2022, Independent Director at Mirati Therapeutics, Inc. from 2013 to 2024, Independent Director at Ardea Biosciences, Inc. from 2008 to 2012, Independent Director at DMK Pharmaceuticals Corp.
from 2011 to 2014, Director at Veracyte SD, Inc. from 2015 to 2018, Director at Tetraphase Pharmaceuticals, Inc., Independent Director at Odonate, Inc. from 2017 to 2022, Chief Financial Officer at PURE Bioscience, Inc. in 2012, Chief Financial Officer, Secretary & Senior VP at NovaDel Pharma, Inc. from 2010 to 2011, Chief Financial Officer & Senior VP-Operations at MitoKor, Inc. from 1994 to 2004, Vice President-Sales at Philip Morris USA, Inc. from 1991 to 2009, Vice President at Raptor Pharmaceuticals Corp.
from 2009 to 2010, Chief Financial Officer & Vice President at TorreyPines Therapeutics, Inc. from 2004 to 2009, Chief Financial Officer & Vice President at TPTX, Inc. from 2004 to 2010, and Vice President at Horizon Pharmaceutical LLC from 2009 to 2010.
Education includes an undergraduate degree from The University of Michigan-Dearborn conferred in 1984.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 14 592 ( 0,01% ) | 223 695 $ | 31/05/2026 | |
| 14/04/2026 | 83 770 ( 0,04% ) | 72 880 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HERON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 13/01/2014 |
| AURINIA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 07/11/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| MIRATI THERAPEUTICS | Directeur/Membre du Conseil | 23/01/2024 |
| LA JOLLA PHARMACEUTICAL COMPANY | Directeur/Membre du Conseil | 22/08/2022 |
| ODONATE, INC. | Directeur/Membre du Conseil | 01/01/2022 |
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Directeur/Membre du Conseil | 01/01/2018 |
| DMK PHARMACEUTICALS CORPORATION | Directeur/Membre du Conseil | 25/08/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 18 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
PURE Bioscience, Inc.
PURE Bioscience, Inc. Chemicals: Major DiversifiedProcess Industries Develops and markets technology-based bioscience products | Process Industries |
NovaDel Pharma, Inc.
NovaDel Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops oral spray formulations | Health Technology |
MitoKor, Inc.
MitoKor, Inc. BiotechnologyHealth Technology Provides discovery and diagnostic development of mitochondrial medicine | Health Technology |
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Philip Morris USA, Inc.
Philip Morris USA, Inc. TobaccoConsumer Non-Durables Manufactures and distributes cigarettes and related tobacco products | Consumer Non-Durables |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
TPTX, Inc.
TPTX, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biopharmaceuticals | Commercial Services |
DMK Pharmaceuticals Corp.
DMK Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of opioid overdose and substance-use disorders | Health Technology |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care | Commercial Services |
The University of Michigan-Dearborn
The University of Michigan-Dearborn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Odonate, Inc.
Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national